Centerra Gold earnings preview: valuation cheap, analysts unconvinced

Centerra Gold arrives at its October 30 results having shed 7.5% over the past month, now trading at CAD 28.52, with the market debate centred less on short-side pressure and more on whether a deeply discounted valuation can hold without a meaningful earnings beat.

The stock's positioning ahead of the print is notably relaxed on the borrow side. Short interest has eased further to just 1.9% of the free float, down another 10% on the week as shorts continued to cover. Borrowing costs are negligible at 0.59%, and availability is extraordinarily loose at over 3,200%. There is no squeeze dynamic in play and no meaningful conviction from the short side coming into results.

The more interesting tension is in valuation and analyst sentiment. The sell-off has pushed Centerra's trailing P/E down to around 10.4x and EV/EBITDA below 5x, both at their lowest levels in 30 days. The earnings yield factor score ranks in the 89th percentile, and EV/EBIT in the 94th, placing Centerra firmly in deep-value territory on a relative basis. The dividend score also ranks in the 94th percentile, though the company has not paid a dividend since 2022 and that history should be read cautiously. Against this, analyst consensus puts the mean price target at CAD 24.12, which is actually below the current trading price of CAD 28.52. That disconnect is notable: the Street sees the stock as overvalued even after the recent pullback, with EPS momentum over the past year ranking in just the 12th percentile on a forward basis. As of October 26 there have been no recent rating changes to update that picture.

On the ownership side, the institutional register has some structure worth noting. L1 Capital added over 9.2 million shares as of June 30, making it the largest holder at 8.4% of shares. Donald Smith, a known value manager, holds 7.9%. Dimensional and Van Eck hold 6.2% and 6.8% respectively, with both making small additions to their positions as recently as late September. The 13D/G register carries no activist, only passive-style holders filing Schedule 13G. BlackRock Portfolio Management notably trimmed its disclosed stake from 7.8% to 3.4% in its October 2025 filing, though stakes are as last disclosed and holders below 5% may not file again.

The last comparable earnings event, in late July, produced a 13% single-day gain followed by a further 7% over the following five days. The print before that saw a modest one-day dip before a 15% five-day recovery. The question the October 30 report will test is whether operational execution at Centerra's core assets can justify a stock that value screens love but analysts have been reluctant to upgrade.